psychedelic drugs

Letter Shows Feds are Gearing Up for Psychedelic Drug Approvals

A recently published letter (“Letter”) indicates that the Biden administration is preparing for the approval of psychedelic drugs and MDMA to treat mental illness and PTSD. This type of federal agency correspondence would have been unimaginable five or six years ago. Things are changing fast! There are well-known potential health benefits of MDMA and psychedelics

microdosing at work

Microdosing at Work

This article was originally published on Bill of Health, the blog of Petrie-Flom Center at Harvard Law School, as part of a digital symposium, A Macro View of Microdosing. In light of the widespread cultural and business culture adoption of microdosing, private sector employers should reconsider the implications of a blanket prohibition on workplace use of controlled substances. What

psychedelics webcast

Join Us January 26! The Future of Psychedelics

Do you want to join us for a webcast about the future of psychedelics? If so, you won’t want to miss the Seminar Group’s upcoming, day-long psychedelics webcast, Legal and Regulatory Landscape for Psychedelics. The webcast will take place virtually on Wednesday, January 26, 2022, starting at 9:00 AM PST. Harris Bricken attorney Griffen Thorne

ketamine chemistry structure drawn on chalk board

Ketamine Clinics and the Corporate Practice of Medicine in California

Ketamine clinics are increasing in number in the United States and globally. As we described previously, ketamine is a Schedule III drug under the federal Controlled Substances Act, has been approved by the Food and Drug Administration (FDA) for certain medical uses, and may in some cases be used for off-label uses (such as anxiety